Introduction
Coronavirus-induced respiratory diseases in human first reported in
Wuhan, China on December 31, 2019 quickly broke out in other parts of
China and other countries (1,
2). The entire human population is at risk
for contracting coronavirus disease
(COVID-19)(3). Given the immune and
anatomical changes during pregnancy, pregnant women are more vulnerable
to the virus. The COVID-19 pandemic can therefore cause serious
consequences for pregnant women (4-7). The
clinical features and effects of COVID-19 during pregnancy and the
prenatal outcomes of COVID-19 patients have rarely been addressed in
literature (8). Moreover, COVID-19
associated infections have never been reported in molar pregnancy
(9). Clinical experience with managing
pregnant women and newborns with COVID-19 is also limited in
China(10).